PTC
BIVI icon

Philadelphia Trust Company’s BioVie BIVI Stock Holding History

Philadelphia Trust Company’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97K Sell
50,010
-25,000
-33% -$39.3K 0.01% 263
2026
Q1 		$105K Hold
75,010
– – 0.01% 259
2025
Q4 		$87K Hold
75,010
– – 0.01% 252
2025
Q3 		$143K Buy
+75,010
New +$304K 0.01% 249

Other funds holding BIVI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Philadelphia Trust Company's BIVI Position: Q2 2026 in Review

Philadelphia Trust Company reduced its BioVie (BIVI) stake by 33% in Q2 2026, selling an estimated $39.3K and leaving 50,010 shares worth $97K. The position accounts for 0.01% of the portfolio, ranked #263.

Philadelphia Trust Company first reported a position in BIVI in Q3 2025 and has held it in 4 quarters since. The position peaked at $143K in Q3 2025. 35 funds tracked by Wall St. Rank hold BIVI as of Q2 2026.

  • Philadelphia Trust Company held 50,010 shares of BioVie worth $97K as of Q2 2026.
  • Philadelphia Trust Company sold 25,000 BioVie shares in Q2 2026, an estimated $39.3K.
  • BioVie made up 0.01% of Philadelphia Trust Company's portfolio in Q2 2026, its #263 holding.
  • Philadelphia Trust Company first reported a position in BioVie in Q3 2025 and has held it in 4 quarters since.
  • Philadelphia Trust Company's BioVie position peaked at $143K in Q3 2025.
  • 35 funds tracked by Wall St. Rank held BioVie as of Q2 2026.

Based on Philadelphia Trust Company's 13F filing for Q2 2026, filed 10 Aug 2026.